Background-Pancreatic antibodies occur in about one third of patients
with Crohn's disease. Aims-To evaluate the relevance of pancreatic ant
ibodies as a genetic marker in patients with Crohn's disease and their
first degree family members and spouses. To characterise further panc
reatic antibodies by assessment of IgG subclasses. Methods-Six hundred
and fifty serum samples were tested for pancreatic antibodies by immu
nofluorescence on sections of human pancreas. Incidence of pancreatic
antibodies and their subtypes were studied on 212 serum samples from p
atients with Crohn's disease. In the familial study, 72 patients with
Crohn's disease and 196 first degree family members and 26 patients wi
th ulcerative colitis and 90 first degree family members were included
. Ten healthy families sewed as controls. Results-Pancreatic antibodie
s were found in 58 (27%) of the patients with Crohn's disease and in n
one of the controls. Thirty patients had pancreatic antibodies of subt
ype I characterised by a drop-like fluorescence in the pancreatic acin
i, 28 patients had subtype II with a fine speckled staining in the aci
nar cells. Pancreatic antibodies of subtype I were both IgG1 and IgG2
antibodies by contrast with subtype II which were mainly of IgG1 subcl
ass. Only five of 196 first degree relatives of patients with Crohn's
disease had pancreatic antibodies. Four of these people had anamnestic
data compatible with inflammatory bowel disease. Further investigatio
ns showed Crohn's disease in two of these people. In families with mor
e than one member positive for pancreatic antibodies, pancreatic antib
odies were of the same subtype in all cases. Conclusions-Pancreatic an
tibodies are a specific marker for Crohn's disease. Two subgroups of p
ancreatic antibodies can be distinguished by their pattern and immunog
lobulin subclasses. Pancreatic antibodies rarely occur in family membe
rs of patients with Crohn's disease. These family members may also hav
e Crohn's disease.